Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers

Abstract Background Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs) may help restore limb perfusion in patients with diabetes mellitus and critical limb-threatening ischemia (CLTI) deemed not eligible for revascularization procedures and consequently at risk for major amput...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrea Panunzi, Fabiana Madotto, Elena Sangalli, Federica Riccio, Adriana Barbara Sganzaroli, Paolo Galenda, Amelia Bertulessi, Maria Francesca Barmina, Ornella Ludovico, Orazio Fortunato, Francesco Setacci, Flavio Airoldi, Davide Tavano, Laura Giurato, Marco Meloni, Luigi Uccioli, Antonino Bruno, Gaia Spinetti, Carlo Maria Ferdinando Caravaggi
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-09-01
Col·lecció:	Cardiovascular Diabetology
Matèries:	Critical limb-threatening ischemia Diabetes mellitus Autologous cell therapy
Accés en línia:	https://doi.org/10.1186/s12933-022-01629-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!